Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christel R Brinkmann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The FEBS Journal|February 28, 2013
Protein-fatty acid complexes: biochemistry, biophysics and functionChristel R Brinkmann, Steffen Thiel, Daniel E Otzen
Biochimica Et Biophysica Acta|December 14, 2012
Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytesJesper Reinholdt, Knud Poulsen, Christel R Brinkmann, et al.
Open Forum Infectious Diseases|June 3, 2015
Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous systemThomas A Rasmussen, Martin Tolstrup, Holger Jon Møller, et al.
The Journal of Biological Chemistry|February 5, 2013
Mitochondria and the lectin pathway of complementChristel R Brinkmann, Lisbeth Jensen, Frederik Dagnæs-Hansen, et al.
Mediators of Inflammation|December 24, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 PatientsAne Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, et al.
Journal of Virology|July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with PanobinostatRikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Plos Pathogens|September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S Søgaard, Mette E Graversen, Steffen Leth, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The FEBS Journal|February 28, 2013
Protein-fatty acid complexes: biochemistry, biophysics and functionChristel R Brinkmann, Steffen Thiel, Daniel E Otzen
Biochimica Et Biophysica Acta|December 14, 2012
Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytesJesper Reinholdt, Knud Poulsen, Christel R Brinkmann, et al.
Open Forum Infectious Diseases|June 3, 2015
Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous systemThomas A Rasmussen, Martin Tolstrup, Holger Jon Møller, et al.
The Journal of Biological Chemistry|February 5, 2013
Mitochondria and the lectin pathway of complementChristel R Brinkmann, Lisbeth Jensen, Frederik Dagnæs-Hansen, et al.
Mediators of Inflammation|December 24, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 PatientsAne Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, et al.
Journal of Virology|July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with PanobinostatRikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Plos Pathogens|September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S Søgaard, Mette E Graversen, Steffen Leth, et al.
Pageof 1